Status:
COMPLETED
Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke
Lead Sponsor:
Xijing Hospital
Conditions:
Ischemic Stroke
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of this phase 3 study is to validate the efficacy and safety of ginsenoside-Rd for acute ischemic stroke.
Detailed Description
A phase Ⅲ randomized, double-blind, placebo-controlled, multicenter study was conducted to examine the efficacy and safety of ginsenoside-Rd in patients with acute ischemic stroke. Stroke patients wer...
Eligibility Criteria
Inclusion
- between 18 to 75 years
- the first episode
- from onset to admission within 72 hours
- NIHSS scores:5\~22
Exclusion
- had other intracranial pathologies (e.g., tumor, infection)
- had a neurologic or psychiatric disease
- had a coexisting condition that limited their life expectancy
- had significant drug or alcohol misuse
- had high-grade carotid artery stenosis for which surgery was planned
- were pregnant or nursing
- participated in a clinical trial with an investigational drug or device within the past 3 months
- were unlikely to be available for follow-up
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
390 Patients enrolled
Trial Details
Trial ID
NCT00815763
Start Date
September 1 2006
End Date
September 1 2008
Last Update
December 30 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Department of Neurology , Xijing Hospital
Xi'an, Shaanxi, China, 710032